查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612592

比沙可啶市场：按剂量类型、应用、分销管道 - 全球预测 2025-2030

Bisacodyl Market by Administration Type (Oral Medications, Suppository Medications), Application (Constipation, Neurogenic Bowl Dysfunction), Distribution Channels - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年比沙可啶市值为12.8亿美元，预计到2024年将达到13.5亿美元，复合年增长率为6.49%，预计到2030年将达到19.9亿美元。

比沙可啶是一种刺激性泻药，主要用于刺激肠蠕动和治疗便秘。在市场研究中，其范围涵盖胃肠道治疗药物领域。对比沙可啶的需求源自于不同族群的便秘和肠道管理的常见问题，包括老年人和接受导致排便不规律的药物的患者。其应用包括口服製剂和栓剂製剂，使其能够灵活应对患者需求和偏好的差​​异。最终用途范围涵盖医院、诊所和个人居家照护，推动了强劲的市场需求。影响比沙可啶市场的关键成长要素包括与生活方式相关的消化道疾病发病率的增加、胃肠道健康意识的提高以及全球人口老化（这通常需要定期服用泻药）。最近的机会包括扩展到新兴市场，那里的医疗保健服务正在改善，并开发创新配方以更快地缓解症状并减少副作用。利用这些机会的建议包括与医疗保健提供者建立策略伙伴关係以及开展教育宣传活动，以提高消费者对常规肠道健康的认识。市场成长面临限制，例如腹部痉挛和腹泻等潜在副作用、包括自然疗法在内的替代疗法选择以及药物核准和销售的监管限制。学名药对定价策略的限制进一步挑战了竞争格局。透过探索更温和、更有针对性、副作用最小的配方和扩大预防医学的使用案例，可以促进创新。数位健康整合，例如监测胃肠健康的应用与比沙可啶的使用相结合，也可以提高患者的依从性和结果。该市场的特点是适度成长和竞争，并受到基本健康需求和泻药输送解决方案创新进步的推动。

主要市场统计
基准年[2023] 12.8亿美元
预测年份 [2024] 13.5亿美元
预测年份 [2030] 19.9亿美元
复合年增长率（%） 6.49%

市场动态：揭示快速发展的比沙可啶市场的关键市场洞察

供需的动态交互作用正在改变比沙可啶市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 便秘和神经源性肠功能障碍的盛行率增加
    • 非处方药的采用增加
  • 市场限制因素
    • 比沙可啶生产原料价格波动
  • 市场机会
    • 持续研究并开发创新製剂和药物传递方法
    • 製造方法的技术进步
  • 市场问题
    • 比沙可啶替代品的可用性

波特的五力：驾驭比沙可啶市场的策略工具

波特的五力框架是了解比沙可啶市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解对比沙可啶市场的外部影响

外部宏观环境因素在塑造比沙可啶市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解比沙可啶市场的竞争状况

对比沙可啶市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：比沙可啶市场供应商绩效评估

FPNV定位矩阵是评估比沙可啶市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製比沙可啶市场的成功之路

比沙可啶市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 便秘和神经性肠功能障碍的盛行率增加
      • 非处方药比沙可啶的使用增加
    • 抑制因素
      • 用于生产比沙可啶的原物料价格波动
    • 机会
      • 持续研发创新药物配方及递送方法
      • 製造方法的技术进步
    • 任务
      • 比沙可啶替代品的可用性
  • 市场区隔分析
    • 剂量类型：大量采用非处方 (OTC) 口服药物比沙可啶
    • 用途：提高比沙可啶在便秘和神经源性肠道功能障碍治疗的使用率
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 比沙可啶市场：依管理类型

  • 介绍
  • 口腔医学
  • 栓剂

第七章 比沙可啶市场：依应用分类

  • 介绍
  • 便秘
  • 神经源性肠功能障碍

第八章比沙可啶市场：按分销管道

  • 介绍
  • 医院药房
  • 网路药房
  • 零售药房

第九章 美洲比沙可啶市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太比沙可啶市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲比沙可啶市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 艾伯维向美国FDA 提交额外申请，申请 Linseth（Linaclotide）治疗 6 至 17 岁儿童和青少年功能性便秘的新适应症
  • 战略分析和建议

公司名单

  • Cambrex Corporation
  • Carbogen AMCIS
  • Centurion Remedies Private Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • Enomark
  • Erregierre Spa
  • GlaxoSmithKline plc
  • Joshi Agrochem Pharma
  • Kreative Organics Private Limited
  • Lexicare Pharma Pvt. Ltd.
  • LMG Pharma
  • Mahendra Chemicals
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • Sanofi SA
  • Tiefenbacher API+Ingredients GmbH & Co. KG
  • Zuche Pharmaceuticals Pvt. Ltd.
Product Code: MRR-BF5906741E5D

The Bisacodyl Market was valued at USD 1.28 billion in 2023, expected to reach USD 1.35 billion in 2024, and is projected to grow at a CAGR of 6.49%, to USD 1.99 billion by 2030.

Bisacodyl, a stimulant laxative, is primarily used to treat constipation by stimulating bowel movements. In market research, its scope encompasses the pharmaceutical segment of gastrointestinal treatments. The necessity for bisacodyl arises from the prevalent issues of constipation and bowel management in various populations, including the elderly and patients under medication regimens that cause bowel irregularity. Its application spans both oral and suppository forms, making it flexible for different patient needs and preferences. End-use scope extends across hospitals, clinics, and personal at-home care, contributing to its substantial market demand. Key growth factors influencing the bisacodyl market include the increasing incidence of lifestyle-related digestive disorders, growing awareness about gastrointestinal health, and the aging global population, which often requires regular laxative solutions. The latest opportunities highlight the expansion into emerging markets where healthcare access is improving, as well as developing innovative formulations for faster relief and reduced side effects. Recommendations to leverage these opportunities involve strategic partnerships with healthcare providers and educational campaigns to increase consumer awareness about regular bowel health. Nevertheless, market growth faces limitations such as potential side effects like abdominal cramping and diarrhea, alternative treatment options including natural remedies, and regulatory constraints on drug approval and marketing. The competitive landscape is further challenged by generic alternatives, which may restrict pricing strategies. Innovation can thrive through research into gentler, targeted formulations that minimize side effects, as well as expanding use-cases in preventive care. Digital health integrations, such as apps for monitoring digestive health linked with bisacodyl usage, could also enhance patient adherence and outcomes. The market is characterized by moderate growth and competition, driven by fundamental health needs and innovative advancements in laxative delivery solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 1.28 billion
Estimated Year [2024] USD 1.35 billion
Forecast Year [2030] USD 1.99 billion
CAGR (%) 6.49%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bisacodyl Market

The Bisacodyl Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of constipation and neurogenic bowel dysfunction
    • Increasing adoption of over-the-counter bisacodyl drug
  • Market Restraints
    • Volatile prices of raw materials used in manufacturing of bisacodyl
  • Market Opportunities
    • Ongoing research & developments for innovative drug formulation and delivery methods
    • Technological advancements in manufacturing methods
  • Market Challenges
    • Availability of alternative to bisacodyl

Porter's Five Forces: A Strategic Tool for Navigating the Bisacodyl Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bisacodyl Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bisacodyl Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bisacodyl Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bisacodyl Market

A detailed market share analysis in the Bisacodyl Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bisacodyl Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bisacodyl Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bisacodyl Market

A strategic analysis of the Bisacodyl Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bisacodyl Market, highlighting leading vendors and their innovative profiles. These include Cambrex Corporation, Carbogen AMCIS, Centurion Remedies Private Limited, Cipla Limited, Dr. Reddy's Laboratories, Enomark, Erregierre Spa, GlaxoSmithKline plc, Joshi Agrochem Pharma, Kreative Organics Private Limited, Lexicare Pharma Pvt. Ltd., LMG Pharma, Mahendra Chemicals, Manus Aktteva Biopharma LLP, Merck KGaA, Sanofi S.A., Tiefenbacher API + Ingredients GmbH & Co. KG, and Zuche Pharmaceuticals Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Bisacodyl Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Administration Type, market is studied across Oral Medications and Suppository Medications.
  • Based on Application, market is studied across Constipation and Neurogenic Bowl Dysfunction.
  • Based on Distribution Channels, market is studied across Hospital Pharmacy, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of constipation and neurogenic bowel dysfunction
      • 5.1.1.2. Increasing adoption of over-the-counter bisacodyl drug
    • 5.1.2. Restraints
      • 5.1.2.1. Volatile prices of raw materials used in manufacturing of bisacodyl
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research & developments for innovative drug formulation and delivery methods
      • 5.1.3.2. Technological advancements in manufacturing methods
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative to bisacodyl
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Administration Type: Significant adoption of over-the-counter (OTC) oral bisacodyl
    • 5.2.2. Application: Increasing utilization of bisacodyl in managing constipation and neurogenic bowel dysfunction
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bisacodyl Market, by Administration Type

  • 6.1. Introduction
  • 6.2. Oral Medications
  • 6.3. Suppository Medications

7. Bisacodyl Market, by Application

  • 7.1. Introduction
  • 7.2. Constipation
  • 7.3. Neurogenic Bowl Dysfunction

8. Bisacodyl Market, by Distribution Channels

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Bisacodyl Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bisacodyl Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bisacodyl Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cambrex Corporation
  • 2. Carbogen AMCIS
  • 3. Centurion Remedies Private Limited
  • 4. Cipla Limited
  • 5. Dr. Reddy's Laboratories
  • 6. Enomark
  • 7. Erregierre Spa
  • 8. GlaxoSmithKline plc
  • 9. Joshi Agrochem Pharma
  • 10. Kreative Organics Private Limited
  • 11. Lexicare Pharma Pvt. Ltd.
  • 12. LMG Pharma
  • 13. Mahendra Chemicals
  • 14. Manus Aktteva Biopharma LLP
  • 15. Merck KGaA
  • 16. Sanofi S.A.
  • 17. Tiefenbacher API + Ingredients GmbH & Co. KG
  • 18. Zuche Pharmaceuticals Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. BISACODYL MARKET RESEARCH PROCESS
  • FIGURE 2. BISACODYL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BISACODYL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BISACODYL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BISACODYL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BISACODYL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BISACODYL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BISACODYL MARKET DYNAMICS
  • TABLE 7. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BISACODYL MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BISACODYL MARKET SIZE, BY SUPPOSITORY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BISACODYL MARKET SIZE, BY CONSTIPATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BISACODYL MARKET SIZE, BY NEUROGENIC BOWL DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BISACODYL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BISACODYL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BISACODYL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 144. BISACODYL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. BISACODYL MARKET, FPNV POSITIONING MATRIX, 2023